2-(2,3-DIFLUOROPHENYL)-5-(METHOXYCARBONYL)-1-METHYL-3-PYRROLIDINECARBOXYLIC ACID
|
- $468 - $756
- Product name: 2-(2,3-DIFLUOROPHENYL)-5-(METHOXYCARBONYL)-1-METHYL-3-PYRROLIDINECARBOXYLIC ACID
- CAS: 1096442-76-0
- MF: C14H15F2NO4
- MW: 299.27
- EINECS:
- MDL Number:MFCD08064793
- Synonyms:2-(2,3-DIFLUOROPHENYL)-5-(METHOXYCARBONYL)-1-METHYL-3-PYRROLIDINECARBOXYLIC ACID;2,4-Pyrrolidinedicarboxylic acid, 5-(2,3-difluorophenyl)-1-methyl-, 2-methyl ester
3 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
Package
- 500mg
- 1g
- ManufacturerCrysdot
- Product numberCD21018872
- Product description2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methylpyrrolidine-3-carboxylicacid 95+%
- Packaging1g
- Price$468
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047859
- Product description2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methyl-3-pyrrolidinecarboxylic acid >95%
- Packaging500mg
- Price$599
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number047859
- Product description2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methyl-3-pyrrolidinecarboxylic acid >95%
- Packaging1g
- Price$756
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD21018872 | 2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methylpyrrolidine-3-carboxylicacid 95+% | 1g | $468 | 2021-12-16 | Buy |
| Matrix Scientific | 047859 | 2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methyl-3-pyrrolidinecarboxylic acid >95% | 500mg | $599 | 2021-12-16 | Buy |
| Matrix Scientific | 047859 | 2-(2,3-Difluorophenyl)-5-(methoxycarbonyl)-1-methyl-3-pyrrolidinecarboxylic acid >95% | 1g | $756 | 2021-12-16 | Buy |
Properties
Boiling point :379.0±42.0 °C(Predicted)
Density :1.346±0.06 g/cm3(Predicted)
pka :2.94±0.60(Predicted)
Density :1.346±0.06 g/cm3(Predicted)
pka :2.94±0.60(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|